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ABSTRACT

Author: Kargl, Christopher, K. MS
Institution: Purdue University
Degree Received: August 2018
Title: Conditioned Medium from Dysfunctional Endothelial Cells Negatively Regulates Satellite
Cell Expansion and Differentiation.
Major Professor: Timothy P. Gavin, PhD

Dysfunction of the endothelial lining of the cardiovascular system is a hallmark symptom of both
cardiovascular disease (CVD) and type II diabetes mellitus (T2DM). The dysfunctional endothelial
cell phenotype is characterized by an increase in production and release of inflammatory cytokines
and reactive oxygen species (ROS) and a decrease in nitric oxide (NO) and growth factor secretion.
Evidence has emerged showing a close relationship between endothelial cells and skeletal muscle
satellite/progenitor cells. Skeletal muscle cell growth and differentiation are impaired in oxidative
environments and many endothelial dysfunction-related diseases. The purpose of the current study
is to determine the impact that high glucose induced endothelial cell dysfunction has on the growth
and differentiation of skeletal muscle satellite cells (SkMSC). Human Umbilical Vein Endothelial
Cells (HUVEC) were grown in normoglycemic, 5 mM glucose (CON) media or hyperglycemic,
30 mM glucose (DYS) media for 48 hours to induce dysfunction, after which the media was
collected to be used as conditioned media (CM). Primary human SkMSCs were isolated from the
vastus lateralis of eight lean subjects and subsequently treated with CON or DYS CM for 2, 4, or
6 days. Satellite cells not collected at day 6 were directed toward differentiation in CON or DYS
CM. SkMSC growth, ROS production and differentiation were analyzed via cell counting, MTT
assay, DHE assay, qPCR, immune blotting, and immunocytochemistry. After 6 days of treatment,
SkMSC counts and the number of viable cells were decreased in DYS CM treatment. SkMSC
cyclin D1 was downregulated and caspase-9 was upregulated in the DYS treatment group.
Myogenesis and myotube fusion were impaired in DYS CM treated SkMSC. Abnormal inhibition
of p38 phosphorylation and a non-significant increase in NF-κB activity occurred in late stage
DYS CM treated satellite cells. This study provides evidence that dysfunctional endothelial cells
impair skeletal muscle satellite cell expansion through possible dysregulation of apoptotic and
proliferative pathways. CM from DYS ECs also clearly inhibited muscle satellite cell
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differentiation and myotube fusion via abnormal intracellular signaling. Future studies should
focus on expanding current knowledge on the relationship between endothelial cells and muscle
satellite cells in endothelial dysfunction-related pathologies.
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CHAPTER 1: INTRODUCTION

1.1 The Cardiovascular System and Endothelial Dysfunction
Proper functioning of the cardiovascular system is a key element in sustaining health and
wellness. Cardiovascular disease (CVD) is the most common cause of mortality in the world, with
approximately 30% of annual deaths occurring due to CVD (“WHO | Cardiovascular diseases
(CVDs),” n.d.)WHO 2017). In the United States, cardiovascular disease accounts for roughly 200
billion dollars in medical costs and loss of productivity in the workplace every year (“Heart
Disease Fact Sheet|Data & Statistics|DHDSP|CDC,” 2017). Cardiovascular disease is an umbrella
term for several disorders affecting the cardiovascular system including, but not limited, to
coronary artery disease (CAD), peripheral vascular disease (PVD), atherosclerosis, hypertension,
stroke, and congestive heart failure.
A second health crisis currently impacting millions of people around the world is type 2
diabetes mellitus (T2DM). T2DM is a metabolic condition characterized by the reduced ability of
tissue to respond to insulin signaling. Insulin is a peptide hormone produced in the pancreas that
facilitates transport of glucose from the bloodstream into cells. Decreased insulin action leads to
chronic states of elevated blood glucose that, when untreated, can lead to organ and tissue damage.
Medically, elevated blood glucose or hyperglycemia is defined as having consistent fasting blood
glucose levels of over 126 mg/dl (American Diabetes Association, 2017). According to the
American Diabetes Association, approximately 30 million Americans or 9.4% of the population
has diabetes; a number that most experts agree is on the rise due to increasing levels of obesity and
other risk factors.
One of the areas negatively impacted by T2DM is the cardiovascular system. Recent
research has shown the odds of developing cardiovascular disease is two to five times higher in
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diabetics than in non-diabetics (Leon & Maddox, 2015). Elevated blood glucose levels, in diabetic
and non-diabetic ranges, have been conclusively shown to be associated with cardiovascular
complications and mortality. While the majority of deaths due to hyperglycemia-associated
cardiovascular disease are from coronary heart disease, the peripheral vasculature is impacted as
well. Hyperglycemia promotes atherosclerosis (Vikramadithyan et al., 2005) and impairs the
regression of atherosclerotic lesions in insulin-resistance and hyperlipidemia independent manners
(Gaudreault et al., 2013) in murine models. Under new American Heart Association guidelines,
hypertension is defined as having systolic blood pressure greater than 130 and/or diastolic blood
pressure greater than 80, is another cardiovascular disease with ties to vascular hyperglycemia
(Whelton et al., 2017). A recent review estimates that around 50-75% of adults with hyperglycemia
and T2DM also have hypertension (Colosia, Palencia, & Khan, 2013). Along with correlational
data, links between hypertension and hyperglycemia have been observed that show deficiencies in
the vasotonic regulating endothelial nitric oxide synthase-anchoring proteins in states of elevated
blood glucose (Pojoga et al., 2014).
1.1.1 Characteristics of Healthy Vasculature
The cardiovascular system is comprised of the heart and the vasculature. A healthy vascular
system is key to maintaining cellular and vascular stability. The main responsibility of the vascular
system is to deliver oxygen and nutrients to every tissue in the body. Capillaries are the smallest
blood vessel in the body and are responsible for facilitating the diffusion of molecules from the
blood stream to tissue. Capillaries are comprised of a single layer of endothelial cells that are in
close contact to the target tissue. The single cell layer and short distances between the vessel and
the target tissue serve to enhance diffusion. The other vessels in the vascular system are made up
of a combination of a single layer of endothelial cells, multiple layers of smooth muscle cells to
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control vascular tone, as well as connective tissue, pericytes and fibroblasts. Healthy endothelium
has vasotonic abilities, allowing for control of blood pressure and local blood flow through vessel
dilation and constriction. It also serves as a barrier to prevent migration of large molecules and
smooth muscle cells, facilitates appropriate immune responses and opposes thrombosis (Félétou,
2011).
1.1.2 Vasotonic Regulation by the Endothelium
Vasodilation of blood vessels is a crucial factor in regulating blood flow, and maintaining
a healthy vasculature. The primary molecule responsible for vasodilation is nitric oxide (NO).
Endothelial cells are the principle producer of NO, which is released following production, and
exerts its effects primarily on the smooth muscle cells that control vascular tone. Endothelial nitric
oxide synthase (eNOS) generates NO from the amino acid L-arginine and bioavailable oxygen
(O2) (Salvador Moncada & Higgs, 1993). Endothelium NO production and release is stimulated in
response to normal and abnormal regulatory factors. Changes in shear stress (Uematsu et al.,
1995), acetylcholine (Rees, Palmer, & Moncada, 1989), blood oxygen content, blood flow, and
thrombin lead to an increase in NO release and subsequent vasodilation (S. Moncada, Palmer, &
Higgs, 1991). Exercise is also a potent stimulator of eNOS activity and NO release (Barbosa et al.,
2013; Bode-Böger, Böger, Schröder, & Frölich, 1994). Upon release by the endothelium, NO acts
in a paracrine fashion on smooth muscle cells by directly and indirectly causing myosin light chain
relaxation in a calcium-dependent manner (Blatter & Wier, 1994; Murad, 1986). NO and cyclic
guanosine monophosphate (cGMP) have both been shown to decrease intracellular [Ca2+] via
inhibition of [Ca2+] voltage-gated channels (Blatter & Wier, 1994). A decrease in intracellular
calcium leads to decreased cross bridge cycling and myosin light chain activity, ultimately causing
smooth muscular relaxation and vascular dilation. Endothelial cells also produce and release
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endothelins, which are vasoconstricting molecules that act on smooth muscle cells in a Ca2+
dependent manner to reduce the diameter of the vessel and consequently decrease local blood flow
(Ishikawa, Yanagisawa, Kimura, Goto, & Masaki, 1988).
1.1.3 Dysfunctional Endothelium
Dysfunction of the endothelium leads to vascular complications and is present in all forms
of CVD as well as in diabetes/hyperglycemia, obesity and hypercholesterolemia (Hadi, Carr, & Al
Suwaidi, 2005; Hadi & Suwaidi, 2007; Lobato et al., 2012). Dysfunctional endothelial cells are
characterized by a decrease in vascular permeability, impaired ability to vasodilate, an increase in
inflammatory compounds, reduction of antithrombotic functions, and a decreased ability to
properly facilitate leukocyte action in immune responses. While these characteristics contribute to
the dysfunctional phenotype of the endothelium, impairments in NO-mediated dilation are the
defining characteristic of dysfunction. Decreased NO action arises from decreased synthesis and
increased breakdown of the dilator (Pieper & Peltier, 1995; Stephen B. Williams, Cusco, Roddy,
Johnstone, & Creager, 1996). Loss of endothelial function also leads to an increase in the activity
of inflammatory transcription factors that mediate the release of inflammation-inducing cytokines
and adhesion molecules. These molecules decrease endothelial barrier functions and prompt the
migration of vascular smooth muscle cells and monocytes as well as promote a general proinflammatory environment (Berliner et al., 1995). These characteristics are present in and
contribute to the pathology of chronic vascular diseases.
Impaired vascular function is also associated with T2DM. Diabetic patients possess a
decreased ability to produce and respond to vasodilatory compounds (McVeigh et al., 1992;
Tessari et al., 2010; Stephen B. Williams et al., 1996). In separate studies done by McVeigh et al.
and Williams et al., NO-mediated vasodilation was found to be impaired in non-insulin-dependent
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T2DM. Additionally, the vasculature of diabetics is in a constant pro-inflammatory state due to
endothelial “activation” (Huang & Vita, 2006). Endothelial activation occurs in response to
increased states of inflammation and is characterized by upregulation of adhesion molecules and
other inflammatory cytokines. Activated endothelial cells are related to and contribute to states of
vascular dysfunction. It has been proposed that increases in vascular derived-oxidative stress due
to changes in the extracellular environment play a major role in the development of T2DM
associated vascular dysfunction and CVD (Ceriello & Motz, 2004).
1.2 Oxidative Stress
Oxidative stress arises in cells when the formation of reactive oxygen species (ROS)
chronically exceeds breakdown. Overproduction of the most notable oxidant, superoxide (O2-), is
a critical factor in the development of endothelial dysfunction due to its strong ability to scavenge
NO and reduce the ability of blood vessels to dilate (Thomson, Trujillo, Telleri, & Radi, 1995).
O2- readily reacts with NO to produce peroxynitrite, a cytotoxic oxidant that can, in high doses,
trigger DNA double strand breaks and lead to cellular necrosis (Szabó, 2003). Additionally, ROS
has been shown to decrease eNOS activity in endothelial cells (Gremmels et al., 2015) and
alleviation of oxidants by vitamin antioxidants has been linked to improved vasodilation in diabetic
and hypertensive patients (Solzbach, Hornig, Jeserich, & Just, 1997; Ting et al., 1996). Not only
does ROS inhibit the release and action of NO by endothelial cells, ROS also is released into the
extracellular environment upon production and plays a role in the development and progression of
endothelial dysfunction. Overexpression of endothelial specific-ROS producing enzymes induces
vascular dysfunction in mice models (Bendall et al., 2007; Fan et al., 2014). These data support
the hypothesis that increased oxidative stress in endothelial cells plays an important role in the
development of vascular dysfunction.
1.2.1 Pathway for ROS production
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Production of ROS comes from several molecular pathways in the endothelium but is most
abundantly produced by several NADPH-Oxidase (NOX) isoforms. Three of the seven known
NOX isoforms, NOX 1, 2, and 4, have been identified in endothelial cells, with NOX 1 and 4
believed to be the most active (Panday, Sahoo, Osorio, & Batra, 2015). The oxidases generate
superoxide molecules by reducing oxygen and oxidizing NADPH. Activation of NOX originates
from extracellular molecules reacting with Toll-like receptors (TLRs) on the surface of the cell.
The receptors have been shown to directly increase NOX activity via physical interaction (H. S.
Park et al., 2004). NOX4 binds with a carboxylic acid domain on TLR4, leading to ROS
production. TLRs were originally discovered to play a role in the innate immune system, as they
can bind foreign pathogens and set off cellular mechanisms that lead to the destruction of the
pathogen. Toll-like receptor 4 is the major isoform expressed on the surface of endothelial cells,
and chronic activation has been shown to contribute to vascular dysfunction in cell culture models
(Hernanz et al., 2015; Pan et al., 2015). Increased NOX activity and ROS production due to
extracellular TLR activation is not exclusively brought on by foreign pathogens. TLR activity and
expression can be triggered by smoke particles, presence oxidized-LDL, and hyperglycemic
conditions (Dasu, Devaraj, Zhao, Hwang, & Jialal, 2008; Kaur, Chien, & Jialal, 2012; Rajamani
& Jialal, 2014; L. Wang et al., 2015). In addition, exposure of cultured HUVEC cells to
hyperglycemic media of 30 mM glucose has been shown to induce increased ROS production via
an increase in TLR4-mediated NOX-4 activity (Dymkowska, Drabarek, Podszywałow-Bartnicka,
Szczepanowska, & Zabłocki, 2014; L. Wang et al., 2015).
1.3 Endothelial Growth and Oxidative Stress
Angiogenesis, the growth and creation of new blood vessels, is a response that is triggered
by mechanical stimuli and changes in the metabolic environment (Hudlicka, Brown, & Egginton,
1992). Adequate vascular growth and capillarization is an important factor in wound healing, bone
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and muscle differentiation and regeneration, and leads to enhancement in delivery of metabolic
factors and nutrients to all tissues in the body (Luque, Peña, Martin, Jimena, & Vaamonde, 1995;
Martin & Nunan, 2015; Stegen, van Gastel, & Carmeliet, 2015). Increasing growth of the
vasculature also confers therapeutic benefits on many diseased target tissues. Triggering the
activation of angiogenic mechanisms is believed to have positive therapeutic effects in response
to myocardial and cerebral ischemia, coronary artery disease, and peripheral vascular disease
(Milkiewicz, Ispanovic, Doyle, & Haas, 2006). Angiogenesis is impaired in the vasculature of
diabetic patients due to inhibitory actions on vascular growth factors (Taniyama et al., 2001).
Hyperglycemia has been shown to induce impaired vasodilatory responses in vivo (Bohlen &
Lash, 1993; Tesfamariam, Brown, & Cohen, 1991; B. Williams, 1998) by reduction in bioavailable
nitric oxide.
Several factors contribute to normal endothelial function, growth, and angiogenesis.
Vascular Endothelial Growth factor (VEGF) is a key regulator of vascular growth and is a powerful
mitogen for all types of vascular cells (Ferrara & Davis-Smyth, 1997). VEGF exists in four
different isoforms, with the predominant ones being VEGFA and VEGFB. VEGF can be secreted
by and bind to VEGF receptors in an autocrine or paracrine fashion or can be taken up exogenously
from the blood stream (Ferrara & Davis-Smyth, 1997).
The VEGF response to hyperglycemia-induced cellular stress appears to be dependent on
the type of vascular cells being studied. Diabetes and hyperglycemia are associated with pathology
of the micro and macro vascular systems. Microvascular complications of T2DM include
retinopathy,

neuropathy,

and

nephropathy.

Diabetes-associated

complications

of

the

macrovascular system include stroke, peripheral arterial disease, myocardial infarction,
atherosclerosis, and hypertension (Laakso, 1999).
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Studies done on hyperglycemic microvascular endothelial cells in vivo and in cell culture
models both show similar increases in VEGF expression and protein levels. The up-regulation of
VEGF is heavily believed to have detrimental effects on microvasculature of the retina and the
kidney. Microvascular systems can be damaged in environments where neovascularization and
permeability are upregulated beyond normal physiological conditions. VEGF-induced increases
in permeability and proliferation of vascular cells in diabetic microvascular cells have been
observed in humans and animal models and are believed to contribute heavily to the dysfunctional
phenotype of these vessels (Adamis et al., 1994; Aiello et al., 1994; Miller et al., 1994; S. B.
Williams et al., 1998). Data from cultured kidney and ocular microvascular cells also clearly shows
VEGF elevation in hyperglycemic endothelial cells (B.-S. Kim, Chen, Weinstein, Noiri, &
Goligorsky, 2002; Long, Wang, Wang, Chang, & Danesh, 2010). The theory that elevated VEGF
is the cause of many microvascular complications is further supported by studies showing that
diabetic microvascular complications are attenuated by treatment with VEGF antagonists (Adamis
et al., 1996). It is important however to note that these findings were found in retinal and kidney
microvascular cells. The impact of VEGF and angiogenesis in diabetic skeletal muscle capillaries
is likely positive, as increased skeletal muscle capillarization is associated with increased insulin
sensitivity (Akerstrom et al., 2014). Additionally, adeno-VEGF treatments have been shown to
reverse the impaired angiogenic response to ischemia in diabetic mice (Rivard et al., 1999). High
capillarization and angiogenesis in skeletal muscle is an important characteristic of a healthy
vascular system that can be compromised during states of endothelial dysfunction.
In contrast to microvascular cells, macrovascular diabetic and hyperglycemic endothelial
cells appear to show lower levels of VEGF expression. These decreased levels contribute to the
dysfunction seen in these cell types. Macrovascular diseases benefit from the formation of
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collateral vessels in order to bypass blocked or diseased blood vessels. VEGF plays an important
role in the formation of collateral vessels because of its mitogenic properties. Problems occur in
patients with diabetes because hyperglycemia and diabetes associated endothelial dysfunction can
reduce the ability for macrovascular cells to proliferate and produce VEGF (Z. Yang et al., 2008;
Zanetti, Zwacka, Engelhardt, Katusic, & O’Brien, 2001). VEGF mRNA and protein levels have
been shown to be significantly lower in hyperglycemic macrovascular endothelial cells and is one
of the reasons for increased apoptosis and decreased growth seen in diabetic cell culture models
using HUVECs (Z. Yang et al., 2008).
Angiopoietin is another important growth factor that contributes to normal endothelial
function. Angiopoietin 1 and 2 (ANG1 and 2), the major angiopoietin isoforms contributing to
endothelial cell growth, bind to tyrosine kinase receptors TIE 1 and TIE 2 on the surface of the
cell. It is generally accepted that ANG1-TIE binding stimulates activation of endothelial cell
growth cascades through increased Akt activation and that ANG2 acts as an antagonist to TIE
receptor activation (Maisonpierre et al., 1997). However, ANG2 has been shown in mature
vascular beds to have a stimulatory effect on vascular remodeling (Oshima et al., 2005). This effect
of ANG2 is believed to be dependent on VEGF availability. In endothelial cells with a high
ANG2:VEGF ratio, increases in cell death and destabilization of the vasculature have been noted
(Lobov, Brooks, & Lang, 2002). When VEGF levels are increased, the negative effects of ANG2
are reversed and it acts a stimulator of endothelial cell growth (Lobov et al., 2002). It is likely then
that the decrease in VEGF availability leads to necrosis and instability in the vasculature of patients
with vascular dysfunction.
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1.4 Endothelial Cell Secretion
Endothelial cells are not regularly considered secretory cells; however, it has been well
established that endothelial cells secrete proteins, mRNA, microRNA, and extracellular vesicles
(Ju et al., 2014; Tunica et al., 2009; Voellenkle et al., 2012). Complete analysis of the secretory
profile of high glucose-induced dysfunctional endothelial cells is currently unavailable, but there
is data available that clearly shows alteration of the endothelial secretome in shear stress and
oxysterols induced dysfunction (Burghoff & Schrader, 2011; Eberini et al., 2013; Rosa-Fernandes,
Maselli, Maeda, Palmisano, & Bydlowski, 2017). Analysis of dysfunctional endothelial cells has
been done that plainly shows a decrease in NO secretion and bioavailability due to decreased
activity of eNOS and NO scavenging by superoxide (Rubanyi & Vanhoutte, 1986; Zou, Shi, &
Cohen, 2002). The induction of pro-inflammatory pathways and the reduction of bioavailable NO
in the cell due to chronic oxidative stress causes the increased production and release of cellular
adhesion molecules (CAMs) (De Caterina et al., 1995; Liao, 2013). The endothelial derived
CAMs, vascular cellular adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1
(ICAM-1), are responsible for the recruitment of inflammatory cells to the vasculature and
contribute to the development of cardiovascular disease. A recent RNA sequencing study
conducted in diabetic patients further highlights the changes in endothelial transcription during
diabetes associated dysfunction (Moradipoor, Ismail, Etemad, Wan Sulaiman, & Ahmadloo,
2016). The authors found that diabetic endothelial cells experience an increase in expression of
inflammatory cytokines, cellular adhesion molecules, extra cellular matrix destabilizing
metallomatrix proteins (MMPs), vasoconstrictors, and other genes responsible for regulating
endothelial homeostasis. Furthermore, the authors found a decrease in the expression of the
superoxide neutralizing enzyme superoxide dismutase, which is consistent with previous findings
showing increased production and release of reactive oxygen species in dysfunctional endothelium
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(Inoguchi et al., 2000; Zhu et al., 2015). Research has also been done that shows decreased
production and release of vascular derived growth factors in hyperglycemic cultured cells.
1.4.1 Endothelial Secreted factors and Skeletal Muscle
Similarly, ECs can exert effects on skeletal muscle cells. Cultured endothelial cells show
the ability to enhance muscle satellite cell growth through the release of IGF-1, HGF, bFGF,
PDGF-BB, and VEGF. Muscle satellite cell proliferation decreased between 41-62.5% following
the individual inhibition of each of the five identified growth factors in satellite and endothelial
cell co-cultures (Christov et al., 2007). In the same study, the authors found that indirectly coculturing muscle satellite and endothelial cells resulted in a 2.5-fold increase in satellite cell
proliferation after seven days compared to growing satellite cells on their own (Christov et al.,
2007). Similarly, conditioned medium from ECs increases the proliferation and migration of
satellite cells but has no effect on the fusion of terminally differentiated myocytes (Latroche et al.,
2017).
The role of VEGF, in particular, on muscle growth has been well studied in the past.
Receptors for VEGF are present on the surface of skeletal muscle stem cells and are highly
sensitive to changes in VEGF levels (Arsic et al., 2004; Bryan et al., 2008; Germani et al., 2003).
During myogenic differentiation of satellite cells, an increase in VEGF receptor expression occurs
and mirrors the increase in myosin heavy chain (MHC) which is a marker of myogenic
differentiation (Germani et al., 2003). It is currently unknown whether the presence of a
dysfunctional endothelium leads to impairments in the growth and differentiation of skeletal
muscle cells.
1.5 Skeletal Muscle: Growth and Differentiation
Skeletal muscle is among the most abundant tissues in the human body, making up
approximately 30-40% of the average person’s body mass. Normal skeletal muscle functions
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include adequate force production to facilitate body movement, the generation of heat through high
amounts of metabolic activity, the storage of macromolecules, and the ability to generate large
amounts of ATP through glycolytic and oxidative metabolism.
1.5.1 Skeletal Muscle Satellite Cell Proliferation and Myogenesis
Adult skeletal muscle cells, or myotubes, are multinucleated cells formed by the fusion of
skeletal muscle progenitor cells known as skeletal muscle stem cells or satellite cells (Moss &
Leblond, 1970). Satellite cells are mononucleated, quiescent, reside underneath the basement
membrane of differentiated myotubes and comprise approximately 3-7 percent of the total skeletal
muscle nuclei (Mauro, 1961; Schultz, 1984). Satellite cells can enter the cell cycle in order to assist
in the regeneration and remodeling of myofibers in response to cell injury or as a part of normal
muscle maintenance (Lipton & Schultz, 1979; T & H, 1992). Satellite cells are characterized by
the expression of paired box transcription factor 7 (Pax 7), which is present in the nucleus (Seale
et al., 2000). Upon activation by extracellular stress and signaling, satellite cells enter the cell
cycle, are referred to as myoblasts, and become highly proliferative. Myoblasts are mononucleated
muscle progenitor cells that eventually exit the cell cycle and differentiate into multinucleated
myotubes.
Differentiation of myoblasts into myotubes is highlighted by a decrease in expression of
the transcription factors Pax7 and Pax3 and an increase in the expression of the myogenic
regulatory factors (MRFs), which are key transcriptional regulators of early and late stage
differentiation of muscle progenitor cells (Edmondson & Olson, 1989; Hasty et al., 1993; Olguin
& Olwin, 2004; Yablonka-Reuveni & Rivera, 1994). The four transcription factors that make up
the MRF family are, myogenic regulatory factor 4 (Mrf4), MyoD, myogenic factor 5 (myf5) and
myogenin. After satellite cell activation in mature skeletal muscle, transcription of the MRFs
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increase and begin to direct myoblasts through the myogenic program. Early myogenesis and
satellite cell expansion is characterized by expression of Myf5 and MyoD, these factors are heavily
expressed while the myoblast is progressing through the cell cycle (Lindon, Montarras, & Pinset,
1998; K. Zhang, Sha, & Harter, 2010). Activated satellite cells that express Myf5 and MyoD still
maintaining expression of Pax7. Myf5 is the first MRF to be expressed during myogenic
commitment and it, along with Pax7, is downregulated as Myogenin and Mrf4 expression are
increased and the cell enters the terminal phase of the myogenic program (Montarras et al., 1991).
In vivo, myogenin expression is required for full embryonic muscle development to occur, whereas
individually knocking out MyoD, Myf5 or Mrf4 in mouse and cell culture models still leads to
fully formed myotubes (Zammit, 2017). In adult satellite cell culture models, however, myogenin
inactivation does not inhibit full differentiation, as there appears to be a compensatory increase in
expression of the other MRFs to allow for full myotube development to occur (Meadows, Cho,
Flynn, & Klein, 2008). Increased MyoD expression in the early phase of the myogenic program
leads to an increase in myogenin expression and full differentiation of the muscle cell (Deato et
al., 2008; Tapscott, 2005). MyoD and myogenin work synergistically to modulate transcription of
muscle specific genes (Cao et al., 2006). Myogenin necessitates complete exit from the cell cycle
by downregulating proteins involved in cell cycle progression and DNA replication (Davie et al.,
2007). The final MRF to be expressed in the myogenic program is MRF4, which is present only
at the conclusion of differentiation and is the most highly expressed MRF in mature muscle
(Sambasivan et al., 2013; Zhou & Bornemann, 2001)
Differentiating myoblasts fuse together to become multinucleated myotubes or myocytes
(M. Zhang & McLennan, 1995). These cells are responsible for the contractile properties of
skeletal muscle. In tissue, skeletal muscle cells, or fibers, are arranged in bundles, and are
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surrounded by connective tissue and a network of capillaries. Appropriate capillarization of
skeletal muscle is crucial for the health and growth of the tissue. The capillary bed of skeletal
muscle allows for the transfer of oxygen, metabolites and, other factors needed for proper muscle
growth and function.
1.5.2 Regulation of Satellite cells by p38 MAPK
Mitogen-activated protein kinases (MAPKs) are cell signaling proteins that are vital to
regulating cellular responses to extracellular stimuli in all cell types. MAPKs play distinct and
important roles in satellite cell activation, proliferation, and differentiation. The p38 MAPK is
especially important in activating and regulating the satellite cell life cycle. Evidence of p38’s role
in satellite cell activation is well established. After activation of satellite cells by extracellular
stimuli, two of the four p38 MAPK isoforms (α and β) localize in the nucleus prior to MyoD
expression and cell division (Jones et al., 2005). P38 MAPK functions downstream of fibroblast
growth factor (FGF), a common growth factor involved in the activation of satellite cells,
providing a possible connection between satellite cell activation and p38 phosphorylation. Jones
also found that inhibition of p38 α /β leads to reduction of MyoD positive cells and a sharp decline
in satellite cell proliferation after 96 hours on cultured intact mouse myofibers (Jones et al., 2005).
Increased p38 signaling is also a well-established and necessary component of the normal
myogenic program. The α /β subunits of p38 are activated as part of the myogenic program in
myoblasts, and inhibition of p38 signaling in myoblasts prevents full differentiation (Brien,
Pugazhendhi, Woodhouse, Oxley, & Pell, 2013; Charville et al., 2015; Q.-C. Liu et al., 2012; Z.
Wu et al., 2000; Zetser, Gredinger, & Bengal, 1999). Induction of p38 appears to be such a
powerful driver of differentiation that increased p38 signaling leads to terminal differentiation of
highly proliferative muscle-derived rhabdomyosarcoma tumor cells and of cells in high serum
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environments (Puri et al., 2000). P38 activation triggers differentiation via increasing expression
of and phosphorylation of the differentiation driving proteins MyoD and myocyte enhancing factor
2 A and C (MEF2A/C) (Han, Jiang, Li, Kravchenko, & Ulevitch, 1997; Zetser et al., 1999; Zhao
et al., 1999).
Outside of its role in growth and cell cycle regulation, p38 is also activated in response to
oxidative stress and can trigger inflammatory and apoptotic responses when acutely dysregulated
(Henriksen, Diamond-Stanic, & Marchionne, 2011; Z. Liu & Cao, 2009). The abnormal activation
of p38 has been repeatedly implicated as one of the pathways contributing to insulin resistance and
dysfunction in type II diabetics. There are great amounts of evidence supporting the notion that
p38 is involved in the development of dysfunction and insulin resistance in endothelial cells and
macrophages in diabetics (Henriksen et al., 2011; Z. Liu & Cao, 2009). The role of skeletal muscle
p38 in oxidative environments, however, is not as clear cut. Environmental changes induced by
exercise activate p38, leading to increases in glucose transport and mitochondrial biogenesis
(Kramer & Goodyear, 2007). In diseased states however, chronically upregulated p38 is associated
with increased inflammatory cytokine expression in mature muscle cells (Brown et al., 2015; J.
M. McClung, Judge, Powers, & Yan, 2010).
Irregular activation of p38 driven by oxidative stress in mature muscle instead of sustained
p38 activation as part of the myogenic program in satellite cells may be the source for the different
effects of p38 signaling in skeletal muscle. It is also possible that the type of stimuli causing p38
activation is responsible for its different roles in skeletal muscle, with oxidative stress and
inflammatory signaling causing activation of inflammatory and apoptotic pathways and growth
factor and mechanical driven activation causing increased insulin action in diabetic cells. In
support of this notion, Wu et al. has shown that the myogenic role of p38 occurs in the absence of
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stimulation of c-Jun N-terminal Kinase (JNK), another MAPK, distinguishing myogenic p38
signaling from p38 signaling in response to inflammatory and oxidative stress (Z. Wu et al., 2000).
Other studies support this and show that downregulation of JNK during differentiation may be
microRNA driven (Xie et al., 2018). In further support of the different sources of p38 action,
oxidative stress-driven acute p38 activity has been shown not to impact differentiation of
myoblasts (Puri et al., 2000; Z. Wu et al., 2000).
1.6 Skeletal Muscle Function, Vascular Dysfunction, and Oxidative Stress
Due to its high metabolic capacity, skeletal muscle function is critically dependent on the
delivery of oxygen and nutrients from the vascular system. Although the vascular system is
comprised of many cell types, capillaries, the blood vessels in direct contact with skeletal muscle,
consist only of a single layer of endothelial cells and do not contain layers of smooth muscle or
connective tissue. Skeletal muscle fibers are in close contact with capillaries to ensure optimal
oxygen and nutrient diffusion from the blood stream (Baba, Kawamura, Shibata, Sohirad, &
Kamiya, 1995). While capillaries are interspersed among skeletal muscle, there have been
observations of capillary-satellite cell niches (Christov et al., 2007). That is, satellite cells are
found to be contained in juxtavascular colonies and are more closely associated with capillaries
than mature muscle. Furthermore, the proximity of the muscle precursor cells to capillaries is
positively correlated with myogenic differentiation. Christov et al. also note that satellite cells
remain co-localized with capillaries even after activation of differentiation. These findings suggest
that endothelial cells play an important role in satellite cell activation, function, and differentiation.
It is then possible that endothelial cell dysfunction could lead to impairments in the function,
growth, and differentiation of skeletal muscle progenitor cells.
Defects in proper endothelial function can impair the diffusion of factors from the
endothelium to individual skeletal muscle fibers. The loss of skeletal muscle mass, or sarcopenia,
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is also more pronounced in hyperglycemic/diabetic patients, as several studies have shown (T. N.
Kim et al., 2010; Leenders et al., 2013; Lim et al., 2010; S. W. Park et al., 2009). In fact, sarcopenia
along with impaired muscle function and decreased exercise tolerance are associated with many
forms of vascular dysfunction (Drexler et al., 1992; Leenders et al., 2013). Patients with
hyperglycemia and diabetes associated endothelial dysfunction often have impairments in skeletal
muscle function. Sarcopenic populations in general experience decreased skeletal muscle
regeneration, primarily due to deficiencies in the satellite cell population. Satellite cells from aged
mice lose the ability to maintain normal quiescent states, causing failure in skeletal muscle
regeneration and satellite cell self-renewal (Sousa-Victor et al., 2014). On a whole body muscular
performance level, muscle strength and quality were decreased in adults with elevated HbA1c
levels, a marker of chronic hyperglycemia (Kalyani, Metter, Egan, Golden, & Ferrucci, 2015).
Diabetes is a complex metabolic syndrome that often involves increased adiposity, insulin
resistance, hyperinsulinemia, hypercholesterolemia, and decreased physical activity, because of
this it is currently impossible to know the specific role hyperglycemia and oxidative stress plays
on diabetic muscle dysfunction.
1.6.1 Oxidative stress and Muscle function
Oxidative stress has been shown to negatively impact myogenic differentiation and satellite
cell function. Decreases in total DNA content and increases in DNA fragmentation, both markers
of apoptosis, are increased in oxidative stress-induced myoblasts (Rathbone et al., 2011; Stangel
et al., 1996). Upregulation of apoptotic pathways in skeletal muscle satellite cells due to increased
oxidative stress depletes the satellite cell pool that drives the muscle generation process in response
to injury and mechanical stimuli. Intracellular morphological and functional changes are also
induced by increased oxidative stress in skeletal muscle stem cells. Sun and colleagues found that
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myoblasts from mice displayed irregular phenotypes when oxidative stress was induced. Increased
stress correlated with a decrease in cellular viability, myoblast size, and disorganization of actin
and other cytoskeleton linking proteins. The cytoskeletal breakdown was consistent with
observations of reduced muscle cell stiffness and decreased actin organization leading to the
conclusion that myoblast biomechanics are attenuated in ROS-enriched environments (Sun, Wong,
Mak, & Cho, 2014). Further work has shown that oxidative stress induces fragmentation of
mitochondria, upregulation of organelle unfolding proteins, and activation of apoptotic pathways
(L. Cai et al., 2002; Iqbal & Hood, 2014). This suggests that increased oxidative stress can cause
stark morphological changes in skeletal muscle myoblasts that impair normal cellular functions.
Disease associated increases in oxidative stress also have negative impacts on the
progression of the myoblast through the cell cycle. In normal skeletal muscle development,
satellite cells become activated and shift from a quiescent state to a proliferative one in times of
muscle formation and regeneration. Murine models of hyperglycemia induced oxidative stress
have shown a decrease in proliferative and regenerative ability of myoblasts following muscular
injury (Nguyen, Cheng, & Koh, 2011). Similar animal models have also shown that the transition
from proliferation to differentiation is impaired during periods of diabetic oxidative stress. These
models demonstrate a decreased expression of MyoD, myogenin and other differentiation
associated transcription factors, culminating in decreased myotube formation (Aragno et al., 2004).
The available literature clearly shows that models of oxidative stress impair skeletal muscle
regeneration by decreasing the pool of regenerative myoblasts and by attenuating the ability of the
myoblasts to advance through the cell cycle and form mature myotubes.
Several cellular mechanisms could explain the decrease in function and increase in atrophy
seen in hyperglycemic muscle. In mouse myotubes grown in culture, the addition of high glucose
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medium inhibited muscle protein synthesis, increased protein degradation, activated apoptotic
pathways and enhanced formation of muscle derived-ROS (T. Yu, Sheu, Robotham, & Yoon,
2008; Zorov, Filburn, Klotz, Zweier, & Sollott, 2000). Hyperglycemia also alters mitochondrial
function, mainly through ROS induced oxidative damage. Elevated levels of intracellular glucose
cause an increase in mitochondrial hyperpolarization, leading to the activation of apoptotic factors
via the mitochondrial permeability transition (MPT) (T. Yu, Sheu, Robotham, & Yoon, 2008;
Zorov, Filburn, Klotz, Zweier, & Sollott, 2000). Therefore, mitochondrial failure and the MPT are
crucial components of the increased apoptosis seen in hyperglycemic cells. Along with oxidative
stress induced increases in mitochondrial mediated apoptosis, the mitochondria of skeletal muscle
show a decreased respiratory capacity and enzyme activity (Mogensen et al., 2007). Oxidative
stress has also been shown to cause a decrease in differentiation through downregulation of the
MRFs leading to an impairment of normal muscle regeneration (Aragno et al., 2004).
Another possible contributor to the impairments in skeletal muscle function seen during
states of vascular dysfunction is chronic systemic inflammation. Endothelial dysfunction is
associated with increased levels of circulating inflammatory markers and cytokines. Tumor
necrosis factor-alpha (TNF-α), C-reactive protein (CRP), monocyte chemoattractant protein 1
(MCP-1), ICAM-1 and VCAM-1 are all secreted and circulate at higher levels in the blood stream
of patients with vascular complications (Botti et al., 2012; Kälsch* et al., 2007; Makino et al.,
2005). Increased circulating levels of two key cytokines, TNF-α and interleukin-6 (IL-6), are
associated with sarcopenia in patients with CVD (Anker et al., 1999; J. P. Li, Lu, Wang, Zhang,
& Shen, 2011; Niewczas et al., 2012). Systemic inflammation has repeatedly been shown to be
associated with sarcopenia in vivo, however there has been some controversy on the effects of
inflammatory cytokines on cultured myoblasts. Elevated levels of CRP have been shown to reduce
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proliferation of otherwise healthy myoblasts (Wåhlin-Larsson, Carnac, & Kadi, 2014). Other
evidence shows that inflammatory markers may increase cell proliferation. Increased proliferation
of mouse myoblasts has been observed in cell culture injury models following treatment with TNFα and IL-6 (Al-Shanti, Saini, Faulkner, & Stewart, 2008; Otis et al., 2014). This would explain the
correlation between increased inflammatory cytokines following muscle injury and increased
muscle regeneration. It appears then that inflammatory cytokines can have a positive influence on
regeneration in response to injury, but chronic states of inflammation elicit negative responses in
satellite cells.
1.6.2 NF-κB Signaling
Production of inflammatory cytokines is facilitated by the NF-κB protein transcription
factors. The NF-κB transcription factors are a complex of DNA binding proteins that target
numerous cell signaling pathways and are important regulators of inflammation, the innate
immune response, mitosis, and cellular growth. NF-κB proteins are regulated by numerous factors,
the most notable ones being the family of IκK and IκB proteins. The IκBs are inhibitory in nature
and bind to NF-κB complexes causing inactivation (Siebenlist, Franzoso, & Brown, 1994). IκBs
dissociate from NF-κB due to IκB-kinase (IKK) phosphorylation (Morgan & Liu, 2011). NF-κB
signaling varies depending on the cell type and has been shown to increase expression of
inflammatory cytokines, inhibit myogenesis, and activate protein degradation systems in skeletal
muscle (D. Cai et al., 2004; Guttridge, Albanese, Reuther, Pestell, & Baldwin, 1999; Mourkioti et
al., 2006).
Reactive oxygen species alter and are altered by NF-kB signaling. Studies on the
interactions between ROS and NF-kB show variable results depending on the situation, cell type
and NF-kB isoform (Morgan & Liu, 2011). In skeletal muscle, ROS causes an increase in NF-kB
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activity via protein kinase C signaling (Dodd, Gagnon, Senf, Hain, & Judge, 2010; Y.-P. Li,
Atkins, Sweatt, & Reid, 1999; Ramana, Friedrich, Srivastava, Bhatnagar, & Srivastava, 2004).
NF-κB activation causes increased expression of the inflammatory cytokines IL-6, TNF-α and IL1β, which all lead to the induction of muscle degradation processes via inhibition of IGF-1 and other
growth factors (Fernández-Celemín, Pasko, Blomart, & Thissen, 2002; Phillips & Leeuwenburgh,
2005). When the balance between protein degradation and synthesis is altered, whole muscular
degradation levels are increased. High levels of degradation cause the destruction of muscle and
lead to decreases in muscle mass and muscle function that negatively impact daily living. In
addition to increasing protein degradation, irregular NF-kB activity negatively impacts the
formation and growth of skeletal muscle fibers by decreasing myotube fusion. Langen and
colleagues have shown that upregulation of TNF-α by NF-kB activation results in inhibition of
myogenic differentiation (Langen, Schols, Kelders, Wouters, & Janssen-Heininger, 2001). This is
supported by the fact that NF-κB is downregulated upon normal muscle differentiation, causes the
upregulation of myogenic inhibitors, and increases the production of factors that maintain
proliferative cell cycle progression (Lehtinen, Rahkila, Helenius, Korhonen, & Salminen, 1996;
Mitin, Kudla, Konieczny, & Taparowsky, 2001; H. Wang et al., 2007). These mechanisms explain
the important regulatory role that NF-κB plays in skeletal muscle and highlight how upregulation
of the transcription factor in diseased states is detrimental to the normal growth and maintenance
of the tissue.
1.7 Aims
Summary
Impairment in skeletal muscle growth and function is often present in patients with different forms
of cardiovascular disease. Dysfunction of the endothelial lining of blood vessels is the hallmark
characteristic of a diseased vasculature. Dysfunctional endothelial cells produce and secrete
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decreased levels of growth factors and vasodilators and increased levels of inflammatory
cytokines, vasoconstrictors, and reactive oxygen species. Skeletal muscle-blood vessel crosstalk
is a key factor in the development of both tissues, due to high concentrations of capillary beds in
skeletal muscle. ROS and inflammatory rich environments are associated with sarcopenia, the loss
of skeletal muscle mass. ROS and inflammation have been shown to induce apoptosis, decrease
myogenesis, and affect cellular proliferation. Chronic activation of NF-kB transcription factors
has been shown to induce and propagate abnormalities in both muscle and vascular dysfunction.
The proximity of capillaries to mature and developing skeletal muscle makes them a target for
examining the mechanisms that could lead to impairments in muscle function that are present in
diseases associated with a dysfunctional endothelium.
Aims
The aims of the current study were to: (i) create a cell culture model to examine the effects of
endothelial cells on human muscle cell function, growth, and differentiation and (ii) to identify if
hyperglycemia-induced EC dysfunction impairs skeletal muscle myoblast proliferation and
differentiation.
1.8- Hypothesis
Hyperglycemia-induced endothelial cell dysfunction lowers skeletal muscle myoblast proliferation
and differentiation through elevation of intramuscular ROS and NF-κB.
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CHAPTER 2: METHODS

2.1 HUVEC Culture
Human umbilical vascular endothelial cells (HUVEC) were grown in M-200 basal
endothelial media (Life Technologies, Carlsbad, CA) containing 5% Fetal Bovine Serum to
facilitate cell growth and a 1% antibiotic mixture to prevent bacterial growth. HUVECs have been
shown in the past to be accurate models in muscle capillarization studies and display a
dysfunctional phenotype after treatment with hyperglycemic medium (Christov et al., 2007; Patel,
Chen, Das, & Kavdia, 2013; Zhao et al., 2017) Cells were initially grown in growth factor
supplemented medium (EGM™-2 BulletKit™, Lonza, Walkersville, MD) until 70-80% confluent.
Cells were then washed and incubated with growth factor free euglycemic (4.5mM) or
hyperglycemic medium (29.5 mM) for 48 hours to induce endothelial dysfunction. This
concentration has been shown to induce endothelial dysfunction in the literature (Du et al., 2001;
Dymkowska et al., 2014) and in unpublished data from our laboratory. Hyperglycemic media was
produced by adding in appropriate amounts of 1M D-glucose (ThermoFisher Scientific, Waltham,
MA) to the basal endothelial medium to achieve a final glucose concentration of 29.5 mM.
Conditioned media (CM) was collected, aliquoted into 15 ml tubes and stored at -80°C and used
later for muscle cell treatment.

2.2 Human Muscle Cell Isolation
Previously isolated primary human muscle satellite cells from muscle biopsies at passage
two were used for this study. Briefly, muscle biopsies from lean subjects were performed on the
vastus lateralis using the modified Bergstrom technique (Evans 1984). Upon completion of the
biopsy, muscle samples were stored in Dulbecco’s Modified Eagle’s Medium (Sigma Aldrich, St.

24
Louis, MO) for transfer to a sterile cell culture hood. Tissue was minced, broken down and
resuspended using a dispase and collagenase mixture. Final cell mixtures were pelleted and
resuspended in Skeletal Muscle Growth Medium (SMGM) (Cell Applications Inc., San Diego,
CA) and grown on cell culture dishes until 80% confluence. Cells were then detached, pelleted,
and resuspended in a freezing buffer containing 90% Fetal Bovine Serum (FBS) (Atlanta
Biologicals, Flowery Branch, GA) and 10% DMSO (ThermoFisher Scientific), and distributed
equally into cryotubes. The cryotubes were then transferred to an isopropanol containing freezing
container (ThermoFisher Scientific) and placed in a -80°C freezer for 24-48 hours, after which the
tubes were transferred to liquid nitrogen for long term storage. Subject characteristics for muscle
biopsy donors are in Table 1.

Table 1. Subject Characteristics. Values are listed as Mean ± SE. n = 8
Characteristic
Mean ± SE Range
Age, y

27 ± 1.6

21-32

Height, m

1.78 ± 0.04

1.6-1.91

Mass, kg

73.2 ± 4.6

58.9-89.1

BMI

22.9 ± 0.8

18.2-25.9

VO2MAX, ml O2×kg-1×min-1

33.6 ± 1.9

27.2-40.4

Glucose (mg/dl)

90.6 ± 3.7

86-109

HOMA-IR

1.9 ± 0.2

1.1-2.6

25
2.3 Conditioned Media Treatments
Human primary myoblasts from eight lean subjects (male n=5, female n=3; Table 1) were
grown in Skeletal Muscle Growth Medium. Cells were passaged at 70-80% confluence and all
experiments involved cells between passage 3 and 5. Cells were treated with 50% control or
hyperglycemic endothelial cell conditioned media (CM) and 50% skeletal muscle growth medium.
Previous experiments conducted in our lab have shown that incubating muscle cells in 100% EC
conditioned medium results in an inability for muscle cells to survive for extended periods of time.
Myoblast proliferation and viability
To properly assess muscle cell proliferation, cell counts were recorded at 2, 4, and 6 days
after treatment with the 50/50 mixture of muscle medium and hyperglycemic or control endothelial
medium. Cells were seeded into 6-well cell culture plates (CellTreat, Pepperwell, MA) prior to
treatments and counts will be determined using a Hemocytometer (Hausser Scientific, Horsham,
PA). Cells were added to a mixture of Trypan Blue before counting and dead cells that are stained
blue were not included in the counts.
Muscle Cell viability was assessed using an MTT assay. MTT assays measure metabolic
activity of cells and can be used to compare the number of viable cells in various samples. MTT
dye is reduced by NAD(P)H oxidoreductase enzymes in the cell to formazan crystals. These
crystals are then solubilized by dimethyl sulfoxide (DMSO) and each sample is read using a
microplate spectrophotometer (ThermoFischer Scientific). Muscle cells were grown to 70-80%
confluence then partitioned into 24-well cell culture plates (Cell Treat) at 10-20,000 cells per well.
Next, the cells were treated with control or hyperglycemic conditioned medium for 24, 48 and 72
hours. Following the treatment, the cells were incubated in 50 ul of MTT reagent (Amresco, Solon,
OH) for 2 hours. Medium and reagent was aspirated out and the myoblasts were detached from
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the plates using 100 ul DMSO and re-plated into 96-well plates (Cell Treat) and the absorbance
read at 550 nm. Absorbance values for each sample were analyzed and the various treatments
compared.
2.4 Human Muscle Cell Differentiation
Primary myoblasts underwent differentiation in control or dysfunctional endothelial cell
conditioned media (CON or DYS CM). Myoblasts were seeded into 6-well plates and grown in
GM/CM splits till confluent, after which the media was replaced with either skeletal muscle
differentiation medium (DM) (2% Horse Serum DMEM) or a 50/50 mixture of DM and
hyperglycemic or normoglycemic EC-CM. Muscle cells differentiating in the CM/DM mixture
were collected at day 6 to assess full myotube differentiation. Cells were then processed and stored
for later RNA and protein analysis as described below.
ROS analysis
Superoxide and other ROS levels were analyzed in CM treated myoblasts. Amount of ROS
was measured using dihydroethidium (DHE), a probe that fluoresces when oxidized by superoxide
and other ROS. Myoblasts were seeded onto 24 well-plates and cells incubated for 2,4 or 6 days
in CON or DYS CM. To control for the independent effect of hyperglycemia on ROS production
in muscle cells (Quintela et al., 2014), an additional control was conducted involving treatment of
muscle cells with 1:1 ratio of skeletal muscle growth media and normoglycemic/hyperglycemic
EC media. Upon completion of the incubation the cells were detached from plates, pelleted, and
resuspended in Hanks’ Balanced Salt Solution stored at 4°C. Then, DHE was added to a final
concentration of 10 μm. Each tube was wrapped in foil, due to DHE’s sensitivity to light, and
incubated at 37 ° C for 30 min. 100 μls of each sample was pipetted into a black bottomed 96-well
plate and read in a fluorimeter at an excitation/emission of 520/610 nm.
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2.5 Immunostaining
Immunostaining was performed on myotubes after incubation with CON or DYS CM.
Cells were collected on day 3 and day 6 of differentiation and washed 3X with phosphate buffered
saline (PBS). A 4% paraformaldehyde fixing solution was added to each well, incubated for 5 min,
and wells washed 3X with PBS. Next, cells were incubated with 100 mM glycine for 15 min and
washed 3X with PBS. Cells were incubated with blocking buffer (5% goat serum+2% BSA+ 0.2%
Triton X-100 and 0.1% Sodium Azide in PBS) for 1-2 hours and washed 3X with PBS. Cells were
incubated in primary antibody diluted in blocking buffer at 4oC overnight. After PBS washing,
cells were incubated with the secondary antibody (Alex568 IgG1, anti-mouse; Cell Signaling
Technologies) and DAPI (Cell Signaling Technologies) at 1:1000 dilution in PBS for 1 hour. DAPI
was used to visualize the nucleus of the cells. Cells were washed 3X times with PBS and visualized
by fluorescent microscopy. Fusion indexes (FI) were used to quantify differentiation. Myosinheavy chain (Cell Signaling Technologies) was stained at each time point in the same manner
described above. Myosin heavy chain (MHC) is increasingly expressed during myoblast
differentiation and can be used as a marker for differentiation status. MHC containing tubes were
co-stained with DAPI, and the number of nuclei per myotube were counted. To be counted as a
tube cells must contain at least 2 nuclei. The FI is the total number of nuclei incorporated into
MHC+ myotubes divided by the total number of nuclei in the field of view, this number is displayed
as percent fusion. Other measures of differentiation generated from these stains are differentiation
indexes (DI), which are the total number of myotubes divided by the total number of nuclei in each
field of view, and average number of nuclei per myotube, which can also be used to interpret the
strength of myoblast fusion. Average myotube size was also determined using ImageJ analysis of
the stained myotubes. Myonuclear Domain (MND) was calculated by dividing average nuclei per
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myotube divided by average myotube size in order to get average area per myonuclei in the average
myotube.
2.6 RNA Isolation, Reverse Transcription, and quantitative real-time PCR
Total RNA was extracted using Trizol reagent (Thermo Fisher Scientific) according to the
manufacturer’s instructions. Briefly, Trizol was added to cells on a cell culture plate, pipetted up
and down several times to lyse cells and collected into 1.5 ml centrifuge tubes. Chloroform was
added to the mixture, centrifuged with the RNA-containing layer removed, mixed with
isopropanol, and again centrifuged to precipitate total RNA. The precipitated RNA pellet is washed
twice with ethanol to remove impurities and resuspended in RNAse free UltraPure distilled water
(Invitrogen, Carlsbad, CA). The RNA concentration was determined by nano-drop (Thermo Fisher
Scientific). For mRNA reverse transcription, first-strand cDNA was generated by random hexamer
primers with MMLV Reverse Transcriptase (Thermo Fisher Scientific). Real-time PCR was
performed using SYBR green based chemistry on a CFX Connect Real-Time PCR detection
System (BioRad, Herculeus, CA, USA). Gene expression was calculated using the 2-ΔΔCt relative
quantification method, as previously described (Livak & Schmittgen, 2001), and a stable
housekeeping gene was used for normalization between samples.
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Table 2. Primer Sequences for mRNA gene expression
Gene Name Gene ID
Forward (5’-3’)

Reverse (5’-3’)

106632259

GGCCCTGTAATTGGAATGAGTC

CCAAGATCCAACTACGAGCTT

GAPDH

2597

ACAACTTTGGTATCGTGGAAGG

GCCATCACGCCACAGTTTC

Mrf4

10865

GGAGCGCCATCAGCTATATTG

ATCCGCACCCTCAAGATTTTC

Mef2c

4208

GAACGTAACAGACAGGTGACAT

CGGCTCGTTGTACTCCGTG

Myf5

4617

CTGCCAGTTCTCACCTTCTGA

AACTCGTCCCCAAATTCACCC

Myogenin

4656

GGGGAAAACTACCTGCCTGTC

AGGCGCTCGATGTACTGGAT

MyoD

4188

CGCCATCCGCTATATCGAGG

CTGTAGTCCATCATGCCGTCG

Cyclin D1

7075

GCTGCGAAGTGGAAACCATC

CCTCCTTCTGCACACATTTGAA

Caspase 3

836

CATGGAAGCGAATCAATGGACT

CTGTACCAGACCGAGATGTCA

Caspase 9

842

CTTCGTTTCTGCGAACTAACAGG

GCACCACTGGGGTAAGGTTT

Atrogin-1

114907

GCCTTTGTGCCTACAACTGAA

CTGCCCTTTGTCTGACAGAAT

Murf-1

84676

CTTCCAGGCTGCAAATCCCTA

ACACTCCGTGACGATCCATGA

VEGFA

7422

AGGGCAGAATCATCACGAAGT

AGGGTCTCGATTGGATGGCA

eNOS

4846

TGATGGCGAAGCGAGTGAAG

ACTCATCCATACACAGGACCC

IL-1β

3553

ATGATGGCTTATTACAGTGGCAA

GTCGGAGATTCGTAGCTGGA

IL-6

3569

ACTCACCTCTTCAGAACGAATTG

CCATCTTTGGAAGGTTCAGGTTG

IL-8

3576

TTTTGCCAAGGAGTGCTAAAGA

AACCCTCTGCACCCAGTTTTC

IL-15

3600

TTGGGAACCATAGATTTGTGCAG

GGGTGAACATCACTTTCCGTAT

TNF-α

7124

CCTCTCTCTAATCAGCCCTCTG

GAGGACCTGGGAGTAGATGAG

18s

2.7 Protein Isolation and Western Blot Analysis
Total protein was isolated from muscle cells using radioimmunoprecipitation assay (RIPA)
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 0.1% Triton X-100,
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and 0.5% Deoxycholate) with protease inhibitor cocktail (Thermo Fisher Scientific) and
phosphatase inhibitor (50 mM NaF and 0.2 mM Na3VO4). Total protein concentration was
determined via BCA Kit (Pierce). Equal concentrations of each sample were added to loading
buffer and loaded onto 10% gels. The gels were in running buffer (0.1% SDS, 25 mM Tris, and
190 mM Glycine) and initially run through electrophoresis at 80 V until the proteins reach the end
of the stacking gel, approximately 10 min. After the samples pass the stacking gel, the voltage was
raised to 100-140 V for 1-2 hours, depending on the size of the protein being examined. The protein
was transferred from gel to PVDF membrane in transfer buffer (190 mM glycine 25 mM Tris, and
20% Methanol) for 1-2 hours. Following the transfer completion, membranes were stained with
Ponceau to probe for total protein. Membranes were washed to remove Ponceau stain and
incubated in blocking buffer, 5% non-fat milk dissolved in TBST (25 mM Tris (pH 7.2), 150 mM
NaCl, and 0.1% Tween 20), for 1 hour at room temperature. Membranes were incubated with
primary antibodies (p-38 MAPK, p-p38 MAPK, ERK, p-ERK, mTOR, p-mTOR, NF-κB, P-NFκB, Akt, P-Akt, Myogenin, MF-20, MyoD) (Cell Signaling Technology) in 5% non-fat milk
dissolved in TBST overnight at 4°C. After incubation, membranes were washed three times in
TBST and incubated in secondary antibody, anti-rabbit or anti-mouse immunoglobulin Ghorseradish peroxidase (Cell Signaling Technology), for 1 hour at room temperature. Membranes
were washed with TBST for 10 minutes three times and images were obtained by
chemiluminescence using ChemiDoc Touch Imaging System (BioRad, Hercules, CA, USA).
2.8 Statistical Analysis
Differences between variables were determined using paired Student’s t-tests. Significance
was established at P ≤ 0.05 for all statistical sets and data will be presented as Mean ± SE.
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CHAPTER 3: RESULTS

3.1- Endothelial Cell Dysfunction
Endothelial cell response to normoglycemic (5 mM glucose) and hyperglycemic (30 mM glucose)
media after a 48-hour treatment is shown in Figure 1. ROS production and TNF-α mRNA levels
had a trend toward increasing in response to hyperglycemia (Fig. 1A and B). Hyperglycemia
decreased the gene expression of VEGFA, superoxide dismutase 2 (SOD2), and eNOS (Fig. 1CE).
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Figure 1. High Glucose induces a phenotype consistent with endothelial dysfunction.
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3.2- Satellite Cell Proliferation and Cell Viability
The human skeletal muscle satellite cells (SkMSC) growth response to normal and dysfunctional
HUVEC CM (CON-CM and DYS-CM) was determined via cell counts and a metabolic viability
assay (MTT) after 2, 4 and 6 days of incubation (Figure 2). After 2 and 4 days of incubation, there
were no differences in the number of SkMSCs between conditions. However, there were fewer
cells in the DYS-CM group after 6 days of CM treatment (Figure 2A). Satellite cell viability was
lower after 4 and 6 days, but not 2 days in DYS-CM compared to CON-CM.
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Figure 2. DYS-CM inhibits cell growth and viability. SkMSC growth at 0, 2, 4, and 6 days after
incubation with HUVEC normoglycemic (CON-CM) and hyperglycemic (DYS-CM) conditioned
media (A). Cell viability as measured via MTT assay at 0, 2, 4, and 6 days after incubation with
CON-CM and DYS-CM (B). *Significantly different from same day control (P ≤ 0.05) MTT assay
Control=1 at each time point. Mean ± SE. n=8 subjects/group.
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3.3 Satellite Cell Survival
SkMSC gene expression in response to 6 days of treatment with CON-CM and DYS-CM is shown
in Figure 3. Cyclin D1 is a major cell cycle regulator and increased expression and activity
promotes progression through the cell cycle (Pyo, Choi, Oh, & Choi, 2013). After 6 days of
incubation, Cyclin D1 mRNA levels were lower in the DYS-CM samples compared to CON-CM
treated cells (Figure 3A). Cyclin dependent kinase-4 (CDK4) gene expression was not altered
between the two treatments (Figure 3B). In the DYS-CM treatment, caspase-9 mRNA, but not
caspase-3, was increased compared to CON-CM (Figure 3C and D).

34

A)

B)

C y c lin D 1 m R N A

CDK4 mRNA
1 .5

p = 0 .2 3 7

P < 0 .0 1
F o ld C h a n g e

F o ld C h a n g e

1 .5

1 .0

0 .5

1 .0

0 .5

0 .0

0 .0

C

o

n

tr

o

C

l

M
D

y

s

C

M
C

C)

o

n

t

ro

l

D

y

s

C

M

caspase 9 m RNA

p = 0 .3 1 7

2 .0

F o ld C h a n g e

1 .0

0 .5

0 .0

p < 0 .0 1

1 .5

1 .0

0 .5

C

M

M

C

s
y

C

l

s

D

D

y

o

M

tr

n

C

n

o

l

o

C

o
tr

M

0 .0

C

F o ld C h a n g e

M

D)

Caspase 3 m RNA
1 .5

C

Figure 3. Cell survival genes in satellite cells treated for 6 days with DYS-CM or CON-CM. Cyclin
D1 is decreased in muscle satellite cells treated for 6 days with DYS-CM (A). CDK4 (B) and
caspase-3 (C) gene expression were not different between the two treatments. Caspase-9 gene
expression was elevated in the DYS-CM cells (D). *Significantly different from same day control
(P ≤ 0.05). Mean ± SE. n=8 subjects/group.

3.4- Satellite Cell ROS Production and NF-kB
SkMSC ROS and NF-κB protein levels are shown in Figure 4. There were no differences in ROS
between the two CM treatments at any time point (Figure 4A). Intracellular ROS was related to
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greater phospho/pan-NFκB ratios when combining all analyzed day 6 SkMSC (Figure 4B). There
was a trend (p=0.08) toward increased phosphorylation of NF-κB in CON-CM DYS-CM treated
SkMSC (Figure 4C).
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Figure 4. Intracellular ROS production and NF-κB phosphorylation in CON-CM and DYS-CM
treated satellite cells are shown in Figure 4. SkMSC intracellular superoxide levels are not different
at 2,4 or 6 days after treatment (A). NF-κB protein levels were not different between treatments,
however there appeared to be a trend toward greater phosphorylation ratio among the DYS-CM
treated SkMSCs (B). Satellite cell ROS levels were positively correlated to the ratio of p-NF-κB
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Figure (4) continued
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3.5- Satellite Cell Inflammatory Cytokine Expression
Figure 5 shows gene expression for inflammatory cytokines regulated by NF-κB. There were no
differences in the gene expression of interleukin 1β (IL-1β), IL-6, IL-8, IL15 and tumor necrosisfactor alpha (TNF-α) between the two conditions after 6 days of CM treatment (Figure 5 A-E).
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Figure 5. NF-κB signaling in DYS-CM and CON-CM treated cells. There was no change in gene
expression of major inflammatory cytokines after 6 days of treatment (A-E). Mean ± SE. n=8
subjects/group.
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3.6- Satellite Cell Kinase Signaling
Total and phosphorylated protein levels of p38 MAPK, ERK-1/2, Akt and mTOR were evaluated
after 6 days of incubation with the CM treatments and are shown in Figure 6. Phosphorylation of
p38 MAPK was higher in the CON-CM compared to DYS-CM, additionally there is a positive
correlation between p-p38 and myogenin expression in differentiated myotubes (Figure 6D).
There were no differences in the phosphorylation for Akt, mTOR, ERK1, or ERK2 (Figure 6B-E).
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Figure 6. MAPK phosphorylation is decreased in SkMSC after 6 days of treatment with DYS-CM.
P38 MAPK phosphorylation was lower in the DYS-CM group as compared to CON-CM and is
correlated to myogenin protein levels, a marker of differentiation, in differentiated myotubes (D).
Total and phosphorylated ERK1, ERK2, Akt, and mTOR are not different between the two
treatment groups (A-C and E). *Significantly different from control (P ≤ 0.05) Mean ± SE. n=8
subjects/group.
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Figure (6) continued
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Figure (6) continued
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3.7- Satellite Cell Atrophy
Gene expression analysis of muscle atrophy regulating ubiquitin ligases were evaluated in day 6
SkMSCs (Figure 7). After 6 days of CM treatment there were no differences in gene expression
for either MURF-1 or Atrogin-1 between treatments (Figure 7 A and B).
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Figure 7. Atrophy related ubiquitin ligases are not dysregulated in DYS CM cells. No differences
between groups in gene expression for MURF-1 or Atrogin-1 after 6 days of treatment (A and B).
Mean ± SE. n=8 subjects/group.

3.8- Myogenesis Staining
Skeletal muscle cell differentiation data analyzed via immunocytostaining at day 6 is in Figure 8.
Day 6 represents terminal differentiation for cultured human muscle cells, robust expression of
myogenin and myosin heavy chain (MHC) in the current study confirms this. Representative
images of MHC and DAPI stained myotubes are shown after 6 days of differentiation in either
CON or DYS CM (Figure 8 A). At Day 6, myotube fusion index (FI) and the average number of
nuclei/tube were lower in the DYS CM group, indicating impaired myoblast fusion (Figure 8 B
and C). The number of myotubes in a given field of view, known as differentiation index (DI),
were not different between the two groups at day 6 (Figure 8 D). Myotube size was not different
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after 6 days of differentiation between the two CM treatments (Figure 8 E). Myonuclear domain
was calculated by dividing myotube area by number of nuclei per tube and tended (p = 0.051) to
be increased in the DYS-CM group on Day 6 of differentiation (Figure 8 F).
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Figure 8. Skeletal Muscle fusion is impaired at day 6 of differentiation in DYS-CM. Representative
images of MHC and DAPI co-stained myotubes after 6 days of differentiation in both treatment
groups (A). FI and average number of nuclei/tube were impaired in the DYS CM myotubes (B and
C). DI was not different between CON and DYS CM treated cells (D). Myotube size at Day 6 is
not different between the two groups (E). Myonuclear domain was not significantly different
between the two groups, however the data was trending toward an increase in myonuclear domain
among the DYS CM treated cells (p=0.051) (F). *Significantly different from control (P ≤ 0.05)
Mean ± SE. n=8 subjects/group.

3.9- Myogenic Gene and Protein Expression
Myogenic Regulatory Factor (MRF) gene expression and protein markers of differentiation were
analyzed for both treatments in day 6 myotubes and the data is shown in Figure 9. Mrf4 and MyoD
mRNA were both lower in the DYS-CM compared to the CON-CM (Figure 9 B and C). Myogenin
and myf5 mRNA were not different between the CON and DYS CM treatments (Figure 9 A and
D). Myogenesis of CON and DYS CM-treated cells was further analyzed via immunoblotting for
myogenic markers at Day 6 of differentiation. Myogenin and Myosin Heavy Chain, two proteins
expressed during terminal differentiation, were at lower levels in the dysfunctional CM-treated
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cells (Figure 9 E and F). MyoD, another myogenic regulatory factor and an important marker and
regulator of early differentiation was not significantly different between the two treatments groups
(Figure 9 G).
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Figure 9. Myogenic Regulatory Factors (MRFs) gene expression and protein markers of
differentiation. There are no differences in mRNA levels of Myogenin (A) and Myf5 (D) between
the DYS-CM and CON-CM differentiated myotubes. There were lower levels of MyoD (B) and
Mrf4 (C) mRNA in DYS-CM. Myogenin (E) and Myosin Heavy Chain (F) (MHC) protein levels
were both lower in Day 6 DYS EC-CM treated differentiated myotubes. MyoD protein levels were
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not different between the two groups (G). *Significantly different from control (P ≤ 0.05) Mean ±
SE. n=8 subjects/group.
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CHAPTER 4: DISCUSSION

4.1-Main Findings
The main findings of the present study are that human primary skeletal muscle satellite
cells grown in conditioned media (CM) from human umbilical vein endothelial cells (HUVECs)
made dysfunctional after incubation in high glucose (DYS-CM) exhibit decreased cell number and
viability. Terminal differentiation and myotube formation is also impaired by DYS-CM via
alterations in intracellular signaling pathways. These findings suggest that dysfunctional
endothelial cells impair the regenerative properties of satellite cells.

4.2-Endothelial Dysfunction
Cell culture models are frequently utilized to mimic in vivo states of endothelial cell
dysfunction. The addition of 25 mM of glucose to euglycemic (5 mM) cell culture media is
effective in inducing a dysfunctional phenotype in HUVECs (Felice et al., 2010; Zhang et al.,
2011). In addition to glucose concentration, HUVEC exposure time to glucose is also a critical
component in the development of dysfunction. Decreased production of NO and growth factors
and well as an increase in apoptosis and oxidative stress occurs after a minimum of 48 hours of
exposure to hyperglycemic (30mM) media (Zhang et al., 2011). Pilot data was collected to confirm
previous studies and establish development of a dysfunctional phenotype in our model before CM
was collected and used to treat satellite cells. We analyzed gene expression and ROS production
in HUVECs that underwent 48 hours of exposure to hyperglycemic or normal basal endothelial
medium supplemented with low levels of serum, but in the absence of endothelial specific growth

46
factors, as previously reported (Felice et al., 2010; Zhang et al., 2011). In HUVECs, hyperglycemia
induced a three-fold increase in ROS production, increased expression of inflammatory cytokines,
and decreased expression of eNOS and VEGF. Our data are consistent with other reports
demonstrating endothelial cell dysfunction induced by hyperglycemic treatment in HUVECs,
consistent with in vivo endothelial dysfunction (Felice et al., 2010; Patel, Chen, Das, & Kavdia,
2013; Zhang et al., 2011).

4.3-Dysfunctional Endothelial Cells Limit Satellite Cell Expansion
Evidence has emerged over the last several years outlining the impact that endothelial cells
have on the function and growth of muscle satellite cells. Satellite cells are located adjacent to
capillaries and myofibers with more capillaries have greater numbers of associated satellite cells,
consistent with cross talk between the two cell types (Christov et al., 2007; Nederveen et al., 2018).
Indeed, satellite cells grown in endothelial cell (EC) co-cultures exhibit higher rates of growth, a
greater ability to migrate, and improved differentiation than ECs grown alone or in the presence
of fibroblasts or smooth muscle cells (Christov et al., 2007; Latroche et al., 2017). EC derived
growth factors appear to be a driving force for the increased satellite cell growth, as blocking any
one of the five main growth factors (GF), b-fibroblast GF, vascular endothelial GF, insulin like
GF-1, platelet-derived GF, and hepatocyte GF (bFGF, VEGF, IGF-1, PDGF and HGF) resulted in
a significant decrease in satellite cell growth (Christov et al., 2007). Previous research on VEGF
production in hyperglycemic-induced EC dysfunction using HUVECs is inconclusive. One study
has shown HUVECs incubated in hyperglycemic media for 24 hours display increases in VEGF
mRNA (Feng & Chakrabarti, 2012). Other studies have observed decreased VEGF mRNA and
protein levels in HUVECs after 48 hours in high glucose media (Peng, Li, & Li, 2018; M. Yu et
al., 2016). At least 48 hours of exposure to hyperglycemia is required to induce a dysfunctional
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phenotype in HUVECs, thus longer incubation times may be responsible for the different VEGF
responses found in the literature (Zhang et al., 2011). Similarly, HGF production is decreased in
hyperglycemia treated HUVECs and the addition of recombinant HGF reduced hyperglycemiainduced HUVEC death (Morishita et al., 1997). The opposite is observed with PDGF, as high
glucose causes an increase in production of PDGF in HUVECs (Mizutani et al., 1995). IGF-1
production has not been specifically analyzed in HG HUVECs, however IGF-1 treatment has been
shown to prevent hyperglycemia-induced mitochondrial dysfunction and apoptosis in HUVECs
(Li et al., 2009). It should be noted that secretion of these growth factors by hyperglycemic
HUVECs has not previously been analyzed, a more rigorous analysis of growth factors levels in
DYS CM from hyperglycemic HUVECs needs to be done.
Nitric Oxide also plays a role in satellite cell activation, where pharmacological inhibition
of nitric oxide synthase in the muscle of mice resulted in delayed satellite cell activation and
impaired muscle regeneration (Anderson, 2000). No studies have been done on how endothelial
cell derived NO impacts muscle cell activation, however it is possible that EC-derived NO
regulates satellite cell activation due to the two cell types being so closely situated (Christov et al.,
2007). The dysfunctional endothelium is characterized by an increase in oxidative stress and
inflammatory cytokine production and a decrease in NO production and release (Rajendran et al.,
2013).
In the current study, satellite cell expansion was impaired after 6 days incubation in DYS
CM. Two days of treatment caused no differences in cell growth, while four days of treatment
resulted in significantly fewer viable cells and a trend towards decreased cell counts in DYS CM
(p=0.067), and after 6 days of treatment, cell numbers and viability were lower in DYS CM cells.
This timeline for cellular changes to occur is comparable to that found in earlier co-culture and
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CM studies between ECs and satellite cells (Christov et al., 2007; Latroche et al., 2017). Thus,
chronic CM exposure of greater than three days is necessary for the development of an altered
phenotype and future experiments employing CM signaling should reflect this.

4.4 Impaired Mechanisms of Satellite Cell Expansion
Apoptosis and cell division are the two mechanisms chiefly responsible for regulating
changes in cell growth. In the current study these two pathways were explored by examining the
gene expression of several important regulators of cell cycle advancement and apoptosis. Cell
cycle advancement in all cell types is regulated by cyclins and cyclin-dependent kinases (CDKs).
Cyclin D1 expression, accumulation and association with CDK4 and 6 in all cells is required for
advancement through the cell cycle and for expansion of the satellite cell pool in skeletal muscle
(Kurosaka & Machida, 2013). The presence of oxidative stress decreases progression of the
satellite cell through the cell cycle (Fei, Zhu, Tao, Huang, & Zhang, 2015; Rathbone et al., 2011)
and causes downregulation of cyclin D1 transcription after introduction to the environment (Pyo
et al., 2013). Cyclin D1 transcription is also regulated by growth factors; however, they act to
stimulate cell cycle progression whereas ROS inhibits it. Growth factor-induced upregulation of
cyclin D1 mRNA is clearly established in satellite cells and results in advancement through the
cell cycle (Rabinovsky et al., 2003; Winston & Pledger, 1993).
In the current study, cyclin D1 gene expression was reduced in the DYS CM treated cells,
which likely contributed to the decreased number of cells and viability. An increase in intracellular
and extracellular ROS combined with a decrease in growth factor availability may be responsible
for decreased cell cycle progression. The mRNA and cell viability data presented here are far from
conclusive indications that cell cycle progression was impaired, future data will need to be
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collected to determine whether the decreased cell counts and viability reported here were due to
cell cycle regulation or other regulatory mechanisms.
Increased apoptosis could also be contributing to the decreased cell counts and viability
observed after chronic exposure to DYS CM. Apoptosis is induced in satellite cells in the presence
of oxidative stress (Fei et al., 2015) and can be inhibited through the actions of IGF-1 and other
growth factors (Párrizas & LeRoith, 1997; Xiao et al., 2001). Caspases regulate apoptosis and are
upregulated early in the activation of the apoptotic pathway. In the present study, caspase 9
transcripts were elevated in DYS CM treated myotubes, although caspase 3 transcripts were not
different between the treatments. Caspase 9 is the first caspase activated upon apoptosis and a key
regulator of the apoptotic pathway. Activation of caspase 9 leads to increased intracellular ROS
production followed by activation of caspase 3 and other apoptosis regulating proteins (Brentnall,
Rodriguez-Menocal, De Guevara, Cepero, & Boise, 2013). In normal growth conditions in skeletal
muscle myoblasts, silencing caspase 9 results in an increase in cell proliferation and a decrease in
apoptosis regulating genes (Ba & Hwang, 2014). These studies identify caspase 9 as an inhibitor
of cell growth via induction of apoptosis. Increased caspase 9 transcription may be able to explain
the negative effects dysfunctional endothelial cells have on satellite cell expansion in the present
study.
Overall, gene data suggests that an imbalance in regulation of the apoptotic and cell cycle
progression pathways may be responsible for the functional growth differences in DYS CM treated
cells. Dysregulation of these pathways likely contributes to a failure of proper satellite cell pool
enlargement leading to incomplete muscle regeneration in instances of endothelial dysfunction.
More experiments are needed to determine whether the decrease in DYS CM treated cells
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compared to control was definitively due to decreased proliferation, increased apoptosis, or a
combination of the two.

4.5-Impaired Myogenesis in DYS CM Satellite Cells
Normal muscle regeneration and fiber maintenance is satellite cell driven and depends on
the activation of quiescent satellite cells, sufficient myoblast proliferation, and timely
differentiation and fusion to bolster and renew existing myofibers. Besides their roles in enhancing
satellite cell growth (Christov et al., 2007; Latroche et al., 2017), ECs also positively regulate
myogenesis. EC and satellite cell co-culture experiments improved muscle cell migration and
increased the number of myogenin positive cells compared to controls, indicating that ECs enhance
satellite cell differentiation (Latroche et al., 2017). The direct impact of dysfunctional endothelial
cells on muscle cell differentiation has not been analyzed prior to the present study. In rat models,
streptozotocin-induced (STZ) diabetes is associated with development of endothelial dysfunction
(Ding et al., 2005) as well as impairments in muscle regeneration. Diabetic rats with elevated
intramuscular oxidative stress also show a decreased number of satellite cells and impaired satellite
cell activation (Fujimaki, Wakabayashi, Asashima, Takemasa, & Kuwabara, 2016) as well as
lower levels of MyoD and myogenin, which can be reversed after treatment with antioxidants
(Aragno et al., 2004). Interestingly, satellite cells isolated from the vastus lateralis of patients with
heart failure, another population with endothelial dysfunction, display impairments in proliferation
and anti-inflammatory activity compared to healthy age-matched controls but show no differences
in morphology or ability to differentiate and form tubes in cell culture (Sente et al., 2016). This,
along with the data presented in the current study, could provide evidence that satellite cellendothelial cell cross talk, not abnormal satellite cell morphology itself, drives dysregulation of
myogenesis in patients with endothelial dysfunction.

51
After 6 days of treatment with CM/differentiation media (DM) splits, there were decreases
in myogenin and MHC protein levels, significant decreases in two of the four MRF genes, and
decreases in the number of nuclei per myotube and fusion index in the DYS CM treated cells
compared to control. This data clearly shows impaired terminal differentiation in DYS CM treated
cells. It is important to note that treating the satellite cells with high glucose non-conditioned
control media did not impair growth or differentiation, ruling out glucose as the main driver of
satellite cell dysfunction (data not shown). The hypothesis that dysfunctional endothelial cells
negatively regulate in vitro myogenesis is a novel finding that supports previous data outlining an
impaired regenerative response in patients with endothelial dysfunction related pathologies. In
diabetic animal models, muscle regeneration is impaired following muscle damage (Nguyen,
Cheng, & Koh, 2011). However, when using diabetes as a model for endothelial dysfunction it is
difficult to determine whether the effects are driven by diabetes-specific complications and not by
dysfunctional endothelial cells. In terms of whole body performance, muscle strength, mass and
the ability to perform functional movement tests is impaired in those with vascular dysfunction
(Drexler et al., 1992; Kalyani, Metter, Egan, Golden, & Ferrucci, 2015; Leenders et al., 2013).
These in vivo reports were not able to account for a possible causal relationship between factors
secreted by the diseased vasculature and impairments in muscle function and repair. The current
study provides evidence that secreted factors from dysfunctional endothelial cells negatively
regulates myogenesis.
In addition, we also observed a trend toward an increase in myonuclear domain (MND) in
the DYS CM treated cells (p=0.051). The MND represents the average area of cytoplasm that a
single myonuclei is transcriptionally responsible. The traditional theory of hypertrophy and
regeneration in muscle dictates an increase in myofiber size that is driven by an increase in
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incorporated myonuclei. In regenerating and hypertrophying muscle in vivo myonuclear size
increases (Mozdziak, Schultz, & Cassens, 1997; Petrella, Kim, Cross, Kosek, & Bamman, 2006;
Petrella, Kim, Mayhew, Cross, & Bamman, 2008), after which nuclei fuse with the growing
muscle fibers so that each nuclei has a manageable transcriptional domain for which it is
responsible. However, the notion of a rigid MND ceiling has recently been challenged with
convincing evidence (reviewed in Murach, Englund, Dupont-Versteegden, McCarthy, & Peterson,
2018). The development of a satellite cell depleted strain of mice has been critical in evaluating
the importance that satellite cells play in the response to hypertrophic and regenerative stimuli
Satellite cell depleted mice show no impairments in muscle fiber size or mechanical strength in
response to hypertrophic stimuli, suggesting that hypertrophy can occur in the absence of
myonuclear accretion and fusion (McCarthy et al., 2011). Indeed, MND appears to be highly
flexible across different age groups and does not impact muscle fiber hypertrophy and regeneration
in healthy subjects (Murach et al., 2018). The results of the present study show that as myotube
size increases in the DYS CM treated cells, there is not an associated increase in myonuclear fusion
which in turn leads to a greater MND. The importance of MND and myonuclear accretion towards
muscle growth and maintenance in diseased muscle is currently unclear. Future work needs to be
done to determine if disease-induced increases in MND have negative effects on muscle fiber
regeneration and mechanical strength in vivo.

4.6-Intracellular MAPK Regulation in DYS CM Satellite Cells
Induction of myogenesis begins with intracellular signal alterations in late stage myoblasts
to set the stage for the development of terminally differentiated myotubes. p38 MAPK activation
and downstream signaling during the early stages of the myogenic program is required for terminal
differentiation of myotubes (Keren, Tamir, & Bengal, 2006). Indeed, inhibition or ablation of p38
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signaling in myoblasts prevents full differentiation (Wu et al., 2000; Zetser, Gredinger, & Bengal,
1999). Activation of p38 causes downstream expression and phosphorylation of myocyte
enhancing factor 2 (MEF2) and MyoD, which then acts to increase the transcription of itself
(MyoD) and myogenin, leading to commitment towards terminal differentiation (Wu et al., 2000;
Zetser et al., 1999). In the present study, myoblast p38 activation was downregulated after 6 days
of treatment in DYS CM compared to CON. Taken at face value these results may seem
contradictory to the role of p38 in oxidative environments. Treatment of C2C12 myotubes with
hydrogen peroxide also caused an upregulation in p38 signaling that lead to increased expression
of atrophy inducing genes, without alterations to NF-κB and other inflammatory regulating
proteins (Joseph M. McClung et al., 2015). Activation of p38 is found in diabetic myotubes and is
associated with chronic inflammation (Brown et al., 2015) consistent with an earlier study showing
heightened p38 phosphorylation in whole muscle of patients with T2DM (Koistinen, Chibalin, &
Zierath, 2003). It is critical to note that these studies were conducted in already differentiated
myotubes or in whole muscle fibers, not in satellite cells progressing through the myogenic
program.
The aims of the current study were to determine the effects of DYS ECs on satellite cell
growth and differentiation. Phosphorylation levels of p38 MAPK in differentiating myoblasts are
antithetical to those found in fully differentiated adult muscle. Indeed, resting adult muscle has
undetectable levels of p38 phosphorylation (Aronson et al., 1998). Also, acute activation of p38
from stress related signaling does not induce differentiation, leading to the hypothesis that p38
signaling during differentiation is different from p38 signaling in response to cellular stress (Puri
et al., 2000; Wu et al., 2000). p38 phosphorylation is controlled by several upstream MAPK
kinases (MKKs), so it is likely that upstream signaling during myoblast differentiation is different
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than during myotube intracellular stress. The sharp decline in p38 phosphorylation observed in the
current study in DYS CM treated satellite cell shows dysregulation of intracellular signaling. After
several days of growth, satellite cells are committed to the myogenic program and undergo
terminal differentiation upon incubation with DM. In the current study there was a positive
correlation between phosphorylated p38 levels in day 6 satellite cells and myogenin protein
expression, a marker of terminal differentiation, in day 6 differentiated myotubes. Alterations in
p38 signaling are potentially responsible in part for the impairments in differentiation observed in
the DYS CM group after 6 days of treatment in DYS CM/DM splits. The mechanisms responsible
for the decrease in p38 signaling are currently unknown and further analysis of the DYS CM is
warranted to identify the specific compounds responsible for the negative regulation of satellite
cell myogenesis.
Along with p38, other MAPKs (ERK 1 and 2) involved in regulating the balance between
growth and differentiation in the satellite cell were examined to further elucidate the regulation of
intracellular signaling in treated myoblasts. Normal differentiation is characterized by a decrease
in ERK-1/2 signaling and an increase in p38 signaling (Khurana & Dey, 2002). Additionally, ERK
inhibition results in an increase in p38 phosphorylation and satellite cell differentiation, while ERK
stimulation abrogated p38 phosphorylation and differentiation in rat skeletal muscle myoblasts
(Khurana & Dey, 2002). In the present study, ERK phosphorylation was not different between
treatments, which suggests ERK levels are not responsible for the low levels of p38
phosphorylation that occurred in the DYS CM treated cells. Phosphoinositide 3-kinase (PI3K) also
regulates myogenesis (Glass, 2010). PI3K is predominantly activated by IGF-1 and regulates
downstream Akt and mTOR signaling which in turn regulate a myriad of differentiation and
hypertrophy genes including the MRFs (Glass, 2010; S. Y. Yang et al., 2010). Akt also negatively
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regulates muscle atrophy via phosphorylation of FOXO1 and downregulation of the atrophyinducing ubiquitin ligases MURF-1 and atrogin (Gardner, Anguiano, & Rotwein, 2012). In the
current study there were no differences in Akt or mTOR phosphorylation between the two
treatment groups. Furthermore, we found no differences in gene expression of the ubiquitin ligases,
indicating that downstream targets of Akt were not different between the two treatments. This
indicates that the differences in cell expansion and later in differentiation found in our DYS CM
cells are not driven by alterations in Akt and mTOR signaling. Alterations in p38 signaling, not
PI3K signaling, appear to be responsible for the myogenic impairments in the DYS CM treated
cells. This is evidence that growth factor levels in the DYS CM, or specifically IGF-1 levels, may
not be causing impairments in myogenesis.

4.7- Oxidative Stress and NF- κB
In the present study, oxidants or oxidized proteins from the dysfunctional CM could be
responsible for the elevated trends we saw in intramuscular ROS and phosphorylated NF-κB.
Intracellular ROS is a well-documented activator of NF-κB in all cell types (Morgan & Liu, 2011).
In normal satellite cells, classical NF-κB signaling is downregulated upon induction of myogenesis
and retroviral expression of NF-κB results in a reduction of myogenesis (Bakkar et al., 2008). In
cell culture models, decreased NF-κB phosphorylation begins in muscle cells immediately upon
introduction of differentiation medium to the cells and precedes myogenin expression and myocyte
fusion (Bakkar et al., 2008). Elevated activation of NF-κB in myoblasts could be contributing to
the impaired differentiation response observed in DYS CM treated cells in the current study. It is
important to note however that there were no increases in the downstream inflammatory cytokines
transcriptionally regulated by NF-κB. The reason inflammatory cytokine signaling was not
elevated in the DYS CM muscle cells is not currently known. In DYS and CON treated day 6
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myoblasts there was a positive correlation between intramuscular ROS levels and NF-κB
phosphorylation suggesting that high intracellular ROS associated with disease may be causing
overactivation of NF- κB and ultimately impaired differentiation in satellite cells. Failure of a
withdrawal in NF-κB signaling due to sustained ROS-induced activation combined with absence
of an increase in p38 phosphorylation in late stage myoblasts likely impaired the transition from
myocyte to myotube in the DYS CM muscle cells in the current study.

4.8- Muscle Fiber Capillarization
Decreases in muscle fiber capillarization in patients with endothelial dysfunction related
diseases may compound the impaired muscle regeneration observed in these populations. The
muscle of type II diabetics has a significantly lower capillary to fiber ratio compared to normal
controls (Andreassen, Jensen, Jakobsen, Ulhøj, & Andersen, 2014; Solomon, Haus, Li, & Kirwan,
2011). The authors posit that lower capillarization is linked to insulin resistance, however other
studies have shown that low fiber capillarization in patients with endothelial dysfunction are
independent of insulin resistance. Normoglycemic hypertensive (HT) patients have decreased
capillary to fiber ratios compared to age matched healthy controls, but capillary to fiber ratio is not
different between HT patients and HT patients with T2DM, suggesting that insulin resistance is
not required for low muscle fiber capillarization in patients with endothelial dysfunction
(Gueugneau et al., 2016). In addition to hypertension and T2DM, decreased capillarization is found
in patients with chronic heart failure, type I diabetes and sarcopenia in general (Kivelä et al., 2006;
Prior et al., 2016; Schaufelberger, Eriksson, Grimby, Held, & Swedberg, 1995). Skeletal muscle
capillarization is positively correlated to satellite cell activation and expansion of the satellite cell
pool (Nederveen et al., 2018). Healthy subjects with greater capillary to fiber perimeter exchanges
(CFPE) experienced greater muscle regeneration following a muscle damage protocol (Nederveen
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et al., 2018). Additionally, patients with amyopathic dermatomyositis (aDM), a condition
characterized by decreased muscle fiber capillarization without irregular inflammation or
oxidative stress, have decreased satellite cell numbers compared to healthy controls (Christov et
al., 2007). It is likely then that abnormal muscle fiber capillarization due to endothelial dysfunction
could contribute to impairments in satellite cell activation, expansion, and differentiation. Future
studies in the field should examine the roles that endothelial cell secretion and muscle fiber
capillarization play in muscle regeneration.

4.9 Future Studies
Future research into this topic needs to be done to fully understand how dysfunctional
endothelium regulates muscle satellite cell function. Future in vitro studies should revolve around
determining which secreted factors are responsible for the negative effects that dysfunctional ECs
have on satellite cells. EC-derived extracellular vesicles should also be examined and considered
as possible contributors to the negative phenotype that develops in DYS CM treated satellite cells.
After analysis of the dysfunctional endothelial secretome, treatments and interventions should be
utilized to target the secreted components deemed to be detrimental to satellite cells. In vivo models
could also be utilized to examine the extent to which endothelial dysfunction regulates muscle
atrophy. An endurance exercise training study would also be useful in determining whether
increasing capillarization and perfusion to the muscle can reduce endothelial dysfunction related
impairments in satellite cell function.

4.10- Limitations
As with most research projects, there were limitations pertaining to the current study. The
in vivo extracellular environment cannot be completely replicated using a 2D cell culture model.
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There were also several other in vivo factors that were unable to be replicated for this study
including no blood flow component, absence of altered insulin and triglyceride levels that often
accompany endothelial dysfunction, and an inability to accurately account for impairments in
capillarization found in patients with endothelial dysfunction. A more rigorous analysis of the
contents of the dysfunctional CM needs to be done to identify signaling molecules responsible for
the decreased expansion and myogenic ability of the dysfunctional CM treated satellite cells.

4.11- Conclusion
In summary, the current study shows that satellite cell expansion and differentiation is
impaired in the presence of CM from dysfunctional endothelial cells. This is the first study showing
that dysfunctional endothelial cells exhibit a direct negative regulatory role on the natural satellite
cell life cycle. Future studies should be done in culture and in vivo to further investigate the
mechanisms regulating satellite cell and endothelial cell crosstalk in disease and to determine
whether drugs targeting the vasculature and muscle fiber capillarization can impact skeletal muscle
progenitor cells.

59

Figure 10: Summation of Results and Proposed Pathway of Action
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